Dr. Drobyski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9200 W Wisconsin Ave
# Bone
Milwaukee, WI 53226Phone+1 414-805-6817Fax+1 414-456-6321
Education & Training
Medical College of Wisconsin Affiliated HospitalsFellowship, Hematology and Medical Oncology, 1988 - 1990
University of RochesterFellowship, Hematology and Medical Oncology, 1987 - 1988- University of RochesterResidency, Internal Medicine, 1983 - 1986
University of Rochester School of Medicine and DentistryClass of 1983
Certifications & Licensure
WI State Medical License 1988 - 2025- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Tocilizumab for Chronic Graft-versus-Host Disease Treatment Start of enrollment: 2016 Feb 01
Publications & Presentations
PubMed
- 1 citationsBhlhe40 Promotes CD4+ T Helper 1 Cell and Suppresses T Follicular Helper Cell Differentiation during Viral Infection.Christine Nguyen, Matthew Kudek, Ryan Zander, Hongshen Niu, Jian Shen
Journal of Immunology. 2024-06-01 - Type 2 cannabinoid receptor expression on microglial cells regulates neuroinflammation during graft-versus-host disease.Alison Moe, Aditya Rayasam, Garrett Sauber, Ravi K Shah, Ashley Doherty
The Journal of Clinical Investigation. 2024-04-25 - 1 citationsSeverity and organ distribution of chronic graft-versus-host disease with posttransplant cyclophosphamide-based versus methotrexate/calcineurin inhibitor-based allogen...Saurabh Chhabra, James H Jerkins, Kathleen Monahan, Aniko Szabo, Nirav N Shah
Bone Marrow Transplantation. 2024-03-01
Abstracts/Posters
- Single Cell Immune Profiling of Colitogenic T Cells during Acute Graft Versus Host Disease Reveals Two Novel Transcriptionally Distinct CD4+ GM-CSF+ LineagesWilliam R. Drobyski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Recipient Signaling through the Cannabinoid Type 2 Receptor Regulates IL-6 Independent Neuroinflammation during Graft Versus Host DiseaseWilliam R. Drobyski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
